Cai and colleagues found that miR-148a loaded in sEVs could promote GBM progression and metastasis by activating STAT3 signaling via CADM1, and the level of which in body fluids of GBM patients was higher than that of healthy individuals. The gene discussed is CADM1; the disease is glioblastoma.